Pacira Biosciences Inc at Barclays Global Healthcare Conference Transcript
Good morning, everyone. My name is Balaji Prasad. I lead the Specialty Pharmaceuticals coverage for Barclays. Continuing on day 2 of our spec pharma track, I'm delighted to have the management team of Pacira with us. So from Pacira, we have Dave Stack, Chairman and CEO; and Charles Reinhart, CFO.
Dave and Charlie, thank you for taking your time and joining us today.
Thank you for the opportunity.
Questions & Answers
Fantastic. So I think as we look now with the updates that you had recently, and you also provided the Feb monthly sales. The question that I have been getting in the past few weeks since the Q4 call is really about ZILRETTA. I think there still seems to be significant confusion over the manufacturing issues on the contract rates that you had and what it means for your 2020 outlook with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
